Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors. | Int J Mol Sci | 2023 | 38139172 | PubTator, text mining | PubMed |
| Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry. | Biomedicines | 2023 | 38137396 | PubTator, text mining | PubMed |
| The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression. | Cancers (Basel) | 2023 | 38136267 | PubTator, text mining | PubMed |
| Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles. | Curr Oncol | 2023 | 38132377 | PubTator, text mining | PubMed |
| Proteome Profiling of Brain Vessels in a Mouse Model of Cerebrovascular Pathology. | Biology (Basel) | 2023 | 38132326 | PubTator, text mining | PubMed |
| The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges. | Mol Ther Oncolytics | 2023 | 38130701 | PubTator, text mining | PubMed |
| High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. | Nat Commun | 2023 | 38114474 | PubTator, text mining | PubMed |
| A narrative review of antibody-drug conjugates in EGFR-mutated non-small cell lung cancer. | Front Oncol | 2023 | 38107063 | PubTator, text mining | PubMed |
| Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. | MedComm (2020) | 2023 | 38107059 | PubTator, text mining | PubMed |
| The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in pre-cystic epithelial cells revealing a new target for polycystic kidney disease. | medRxiv | 2023 | 38106222 | PubTator, text mining | PubMed |
| Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils. | Front Immunol | 2023 | 38090576 | PubTator, text mining | PubMed |
| Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis. | Cancer Innov | 2023 | 38090386 | PubTator, text mining | PubMed |
| Annual progress of clinical research on targeted therapy for nonsmall cell lung cancer in 2022. | Cancer Innov | 2023 | 38090373 | PubTator, text mining | PubMed |
| Recent advances in immunotherapy for lung cancer. | Cancer Innov | 2023 | 38090371 | PubTator, text mining | PubMed |
| Advances in medical treatment of breast cancer in 2022. | Cancer Innov | 2023 | 38090370 | PubTator, text mining | PubMed |
| Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned. | J Hematol Oncol | 2023 | 38087293 | PubTator, text mining | PubMed |
| Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions. | Curr Treat Options Oncol | 2023 | 38085403 | PubTator, text mining | PubMed |
| CD146-targeted nuclear medicine imaging in cancer: state of the art. | View (Beijing) | 2023 | 38076327 | PubTator, text mining | PubMed |
| Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer. | Int J Mol Sci | 2023 | 38069380 | PubTator, text mining | PubMed |
| Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer. | Int J Mol Sci | 2023 | 38068930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=44